Join The Discussion

 

Clip art: Cutting edge barbershop creates a buzz in Fort Worth

Jonathan Morris is on a mission to create a better grooming experience for men.

read more >

Grocers, retailers flocking to Southlake

With its economic development engine revving at full throttle, Southlake is about to welcome several major retail and commercial projects that underscore its image

read more >

Great Woman of Texas; Stacie McDavid

“I’ve always been a maverick in a number of ways,” says businesswoman and philanthropist Stacie McDavid.

read more >

Thousands rally across US after Ferguson decision

Thousands of people rallied late Monday in U.S. cities including Los Angeles and New York to passionately but peacefully protest a grand jury's decision not to indict a white police officer who killed a black 18-year-old in Ferguson, Mo.

read more >

College debt by state in one easy map

WASHINGTON — It may house some of the most esteemed colleges in the country, but if you want to graduate without backbreaking debt, steer clear of schools along

read more >

Fort Worth-area biotech firm seeks $86M IPO

Coppell-based ZS Pharma, a fomer TECH Fort Worth client, is looking to raise more funds with an $86 million initial public offering, the company said in a filing
The biotech firm recently raised $55 million from some venture capital groups a few weeks back. ZS Pharma is developing a drug treatments for hyperkalemia called ZS-9, a potentially life-threatenening medical condition in which kidneys are unable to excrete potassium.
Founded in 2008 in Indiana, ZS Pharma came to Texas to work with TECH Fort Worth and received a $2 million investment from the Texas Emerging Technology Firm.
JP Morgan Chase and Credit Suisee are the managers of the offering. ZS Pharma would trade on the NASDAQ Global Market under the symbol “ZSPH”.
 

< back

Email   email
hide
Midterms
What was the message of the midterm elections?